This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 December 2023 and includes updates on respiratory virus epidemiology in the EU/EEA, SARS-CoV-2 variant classification, measles, mpox, Mycoplasma pneumoniae, West Nile virus, and MERS-CoV.
Since the beginning of the 2023 transmission season and as of 6 December 2023, EU/EEA countries have reported 707 human cases of WNV infection in Italy (336), Greece (162, of which 1 with unknown place of infection).
Since the beginning of the 2023 transmission season and as of 6 December 2023, EU/EEA countries have reported 707 human cases of WNV infection, 152 outbreaks among equids and 247 outbreaks among birds.
Since the beginning of the 2023 transmission season and as of 6 December 2023, EU/EEA countries have reported 707 human cases of WNV infection in Italy (336), Greece (162, of which 1 with unknown place of infection).
Weekly updates with the latest reports on West Nile virus cases in Europe. Interactive maps and tables updated every Friday, during the transmission season.
The Annual Epidemiological Reports (AERs) are key ECDC publication on the epidemiology of communicable diseases of public health significance in Europe.
Lymphogranuloma venereum (LGV) is a systemic sexually transmitted infection (STI) caused by Chlamydia trachomatis serovars L1, L2, or L3. In 2021, 1 124 cases of LGV were reported by 23 EU/EEA Member States.
For 2021, 27 EU/EEA Member States reported 184 542 confirmed cases of chlamydia infection. The crude notification rate was 74 cases per 100 000 population.
